A Study of the Effects of LY3372689 on the Brain in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy

In brief

This study uses imaging to evaluate how LY3372689 binds to a protein in the brain. This study will be conducted in healthy participants and will last up to approximately 25 days after enrollment. Screening must be completed within 28 days prior to enrollment.

Key facts

Study ID
NCT03944031
Run by
Eli Lilly and Company
People needed
17
Starts
2019-05-08
Expected to finish
2020-02-19
Last updated by the study team
2020-04-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.